Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenal venous sampling outcomes in primary aldosteronism with concurrent versus discontinued mineralocorticoid receptor antagonist
TCTR20230908002Phase 2Enrolling by invitation
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of canrenoic acid in primary aldosteronism (PA), sponsored by Faculty of Medicine, Chiang Mai University. Started Aug 2023; status: enrolling by invitation.
02
Drugs
canrenoic acid
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on TCTR20230908002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230908002.